Price $8.93 |
Market Cap
10.87B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.04
|
P/S
0.66
|
Dividend %
-
|
|
P/CF
348.5
|
P/FCF
-
|
Op. Cash Flow
451K
|
FCF
-0.1
|
|
Op. Margin
-17.90%
|
Net Margin
-24.00%
|
ROE
-39.20%
|
ROI
-9.50%
|
|
ROA
-7.90%
|
EPS Growth
-
|
Current Ratio
1.0
|
Debt/Equity
226.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $7.01 | - | - | 284.5M | Strong Buy |
| ConforMIS Inc (CFMS) | $1.20 | - | - | 247.3M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $2.29 | - | - | 15.9M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.54 | - | - | 110.9M | Strong Buy |
| Predictive Technology Group In (PRED) | $0.10 | - | - | 50.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
